Results 231 to 240 of about 795,661 (293)

HLA‐B*15:21 carrier status is a susceptibility factor of carbamazepine‐induced nonimmediate cutaneous adverse reactions in HLA‐B*15:02‐negative patients: A retrospective cohort study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
After HLA‐B*15:02 screening, the residual risk of carbamazepine‐induced nonimmediate cutaneous adverse reactions is 0.059. Among these HLA‐B*15:02‐negative cases, HLA‐B*15:11 and HLA‐B*15:21 carrier status significantly increases the risk of carbamazepine‐induced nonimmediate cADR.
Warit Ruanglertboon   +11 more
wiley   +1 more source

Correction: Vision-related quality of life in non-neovascular age-related macular degeneration: a protocol for systematic review and meta-analysis. [PDF]

open access: yesEye (Lond)
Sun G   +12 more
europepmc   +1 more source

Oral microbial nitrate metabolism is associated with lower prevalence of prediabetes. [PDF]

open access: yesCell Rep Med
Zhao S   +15 more
europepmc   +1 more source

Closing the gap in Singapore: Gynaecologic Cancer Awareness Month. [PDF]

open access: yesSingapore Med J
Chan GMF   +4 more
europepmc   +1 more source

United in Pediatric Sports Medicine: Knowledge Between East and West Strategies Makes Us Better… Together

open access: yes
Arthroscopy, Sports Medicine, and Rehabilitation, EarlyView.
Henry Ellis, Ted Ganley, James Hui
wiley   +1 more source

Home - About - Disclaimer - Privacy